Ralph Snyderman
Ralph Snyderman, M.D., is the Chancellor for Health Affairs at Duke University, as well as President and CEO of Duke University Health System and James B. Duke Professor of Medicine. He oversaw the development of the Duke University Health System which is was one of the first and few fully integrated academic health systems in the country.[1]
In 1987, Dr. Snyderman left Duke to join Genentech, Inc., a biomedical technology firm in San Francisco, CA, as vice president for medical research and development. A year later he was promoted to senior vice president. While at Genentech, he led the development and licensing of several novel therapeutics and supervised 300 staff members working in pharmacology, clinical research and regulatory affairs.[2]
Board memberships
- Member of the Board of Axonyx Inc
- Member of the Board of Cardiome Pharma Corporation
- Member of the Board of Procter & Gamble (1995-)
- National Academy of Sciences Institute of Medicine